613 related articles for article (PubMed ID: 30115129)
21. Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
Kutlay NY; Pekpak E; Altıner S; Ileri T; Vicdan AN; Dinçaslan H; Ince EU; Tukun FA
Int J Hematol; 2016 Sep; 104(3):368-77. PubMed ID: 27393278
[TBL] [Abstract][Full Text] [Related]
22. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
23. Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
Li XY; Li JQ; Luo XQ; Wu XD; Sun X; Xu HG; Li CG; Liu RY; Sun XF; Chen HQ; Lin YD; Li CK; Fang JP
BMC Cancer; 2021 Jan; 21(1):59. PubMed ID: 33435902
[TBL] [Abstract][Full Text] [Related]
24. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
[TBL] [Abstract][Full Text] [Related]
26. Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature.
Martig DS; Williamson CM; Xu X; Sukov WR; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
Ann Diagn Pathol; 2020 Oct; 48():151588. PubMed ID: 32836179
[TBL] [Abstract][Full Text] [Related]
27. [Copy number variations in pediatric ETV6/RUNX1 positive acute lymphoblastic leukemia].
Zou Y; Zhang L; Liu X; Guo Y; Yang W; Zhang J; Liu F; Liu T; Wang S; Chen X; Ruan M; Qi B; Chang L; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2016 Mar; 54(3):209-13. PubMed ID: 26957068
[TBL] [Abstract][Full Text] [Related]
28. The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
Antillón FG; Blanco JG; Valverde PD; Castellanos M; Garrido CP; Girón V; Letona TR; Osorio EJ; Borrayo DA; Mack RA; Melgar MA; Lorenzana R; Ribeiro RC; Metzger M; Conter V; Rossi E; Valsecchi MG
Cancer; 2017 Feb; 123(3):436-448. PubMed ID: 27683100
[TBL] [Abstract][Full Text] [Related]
29. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
Bokemeyer A; Eckert C; Meyr F; Koerner G; von Stackelberg A; Ullmann R; Türkmen S; Henze G; Seeger K
Haematologica; 2014 Apr; 99(4):706-14. PubMed ID: 24241490
[TBL] [Abstract][Full Text] [Related]
30. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
[TBL] [Abstract][Full Text] [Related]
31. Detection of ETV6 and RUNX1 gene rearrangements using fluorescence in situ hybridization in Mexican patients with acute lymphoblastic leukemia: experience at a single institution.
Pérez-Vera P; Montero-Ruiz O; Frías S; Ulloa-Avilés V; Cárdenas-Cardós R; Paredes-Aguilera R; Rivera-Luna R; Carnevale A
Cancer Genet Cytogenet; 2005 Oct; 162(2):140-5. PubMed ID: 16213362
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
Wang KL; Mei YY; Cui L; Gao C; Liu FF; Zhao XX; Li WJ; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Wu MY; Zhou X; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):285-90. PubMed ID: 24762993
[TBL] [Abstract][Full Text] [Related]
33. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
[TBL] [Abstract][Full Text] [Related]
34. The correction of ETV6/RUNX1 translocation in acute lymphocytic leukemia cells: a new gene targeting system by homologous recombination mechanism.
Akbari M; Ebrahimabadi S; Golalipour M; Shahbazi M; Farazmandfar T
J Appl Genet; 2020 Feb; 61(1):67-73. PubMed ID: 31602594
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetics of long-term survivors of ETV6-RUNX1 fusion positive acute lymphoblastic leukemia.
Konn ZJ; Martineau M; Bown N; Richards S; Swansbury J; Talley P; Wright SL; Harrison CJ
Genes Chromosomes Cancer; 2010 Mar; 49(3):253-9. PubMed ID: 19998443
[TBL] [Abstract][Full Text] [Related]
36. High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005.
Karrman K; Forestier E; Andersen MK; Autio K; Borgström G; Heim S; Heinonen K; Hovland R; Kerndrup G; Johansson B;
Br J Haematol; 2006 Nov; 135(3):352-4. PubMed ID: 16965388
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.
Gabriel AS; Lafta FM; Schwalbe EC; Nakjang S; Cockell SJ; Iliasova A; Enshaei A; Schwab C; Rand V; Clifford SC; Kinsey SE; Mitchell CD; Vora A; Harrison CJ; Moorman AV; Strathdee G
Epigenetics; 2015; 10(8):717-26. PubMed ID: 26237075
[TBL] [Abstract][Full Text] [Related]
38. Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases.
Attarbaschi A; Mann G; König M; Steiner M; Dworzak MN; Gadner H; Haas OA;
Genes Chromosomes Cancer; 2006 Jun; 45(6):608-11. PubMed ID: 16552772
[TBL] [Abstract][Full Text] [Related]
39. Native ETV6 deletions accompanied by ETV6-RUNX1 rearrangements are associated with a favourable prognosis in childhood acute lymphoblastic leukaemia: a candidate for prognostic marker.
Ko DH; Jeon Y; Kang HJ; Park KD; Shin HY; Kim HK; Cho HI; Ahn HS; Lee DS
Br J Haematol; 2011 Nov; 155(4):530-3. PubMed ID: 21569007
[No Abstract] [Full Text] [Related]
40. ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.
Martineau M; Jalali GR; Barber KE; Broadfield ZJ; Cheung KL; Lilleyman J; Moorman AV; Richards S; Robinson HM; Ross F; Harrison CJ
Genes Chromosomes Cancer; 2005 May; 43(1):54-71. PubMed ID: 15704129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
